1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
about
Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial EvidenceIndicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitusAlternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitolCirculating biomarkers of glycemia in diabetes management and implications for personalized medicineCurrent concepts in blood glucose monitoringMetabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery.Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.Consumption of pasteurized human lysozyme transgenic goats' milk alters serum metabolite profile in young pigs.Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patientsComparative associations of diabetes risk factors with five measures of hyperglycemia.Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.Utility of different glycemic control metrics for optimizing management of diabetesGlobal biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.Insulin initiation: bringing objectivity to choice.HOMA-IR Values are Associated With Glycemic Control in Japanese Subjects Without Diabetes or Obesity: The KOBE Study.Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.Metabolomics and renal disease.Gender-specific pathway differences in the human serum metabolome.Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes.Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice.Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic PeopleRacial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.Individual variability in human blood metabolites identifies age-related differences.Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assayMetabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.Glucose Variability: Comparison of Different Indices During Continuous Glucose Monitoring in Diabetic PatientsEvaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.Pitfalls in hemoglobin A1c measurement: when results may be misleading.Metabolite Profiling of 5'-AMP-Induced Hypometabolism.Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes.1,5-Anhydroglucitol in diabetes mellitus.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Validation of a metabolite panel for early diagnosis of type 2 diabetes.How can we easily measure glycemic variability in diabetes mellitus?1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
P2860
Q26752669-5291ABBD-EF99-4BAC-AD65-8AE9A889DE3FQ26799252-60345A0C-534C-4BE2-BEE3-56C4481B0E4FQ26801852-89F5F2C4-5F3B-4B4D-93A2-356CB66B63F2Q27693123-2917BE72-3295-4C14-A149-F856DE359840Q30437091-2FF0585C-7EFE-42ED-B835-EA526C11CA2BQ30913648-06A5FDBB-2500-4F13-80BC-E5934C3A4287Q33767379-F01E034E-F4D6-4710-A41C-0A25761330ACQ33784296-5987C17F-B113-4EC8-A699-BEAF615E3062Q33988007-5B7870D0-DDAE-4D34-B532-23355A59342BQ34284251-E8EB2C63-0302-4E9D-9DE9-8D4CB2E55611Q34419206-6A527630-4D98-402A-9FD4-9E2C40DC62A3Q34425731-EF4EA499-8897-4D5F-B19C-ED3CBDA7C5F0Q34433155-052039D5-94CF-4439-91A0-69651280049EQ35049855-65D02020-AEDF-4C5F-9B5D-F635691E3AB9Q35220587-1BEDD3CB-747D-4F03-A916-C1E733BC7FCFQ35414151-60DDED4A-0C8D-4535-98A9-452B5CF94891Q35649246-3A3146EA-4105-4D78-B257-F669F24D2477Q35688303-CD934419-3F6E-4FD0-9EC9-CB78CA617970Q35778649-1FD42955-EC9B-4045-AC63-D07C859BD2FFQ36162318-DA69627B-6BFE-4BE0-8B68-F6A343610611Q36392849-0FC022CB-BF45-4A64-8562-D004187D55A4Q36488560-F2311C9C-39B3-4787-8A37-011C341BCA3FQ36567359-104D89C7-AB32-4205-889B-F842B4FB226FQ36716070-A046447E-B30D-4582-9D9A-93A025C8737AQ36726169-B1219E25-0B67-450F-9108-4CDFECD94952Q36831445-5E89C736-51DD-4753-8082-C2EE85238340Q36900001-241824C5-9AD9-4BF2-9A6D-DF7F843BA2FFQ36911219-8DF79E7E-7255-4B02-8972-523053C6BAF2Q37016517-F9C16B4F-11FB-4D88-8752-2990D827166FQ37054676-8D005686-9825-4E26-8BCE-6A03DFDAB3B9Q37156757-4B7C6C59-D64E-4AAE-93AF-6FCBD826B861Q37549703-C96A6C2D-550E-42DD-9894-50DABF9FE18AQ37553192-623DB3FF-4253-4EBA-B1A9-2E45BA5EABF1Q37692359-3B9C4BEC-3E61-4BDB-82AB-77DB4E8AAAB6Q38030840-EF265A62-ED52-4E8C-BFEE-8E60B925F96EQ38045278-A674C40F-ABCC-4B4B-8F12-8D1516169E76Q38182542-1DB59EBB-A648-4A10-8D7C-BE0B10C04AE4Q38832879-6258D751-1F49-40DB-A950-9A9A2DA659DCQ39996070-59931217-A9CD-45FB-92D4-41DBE21376D3Q39996202-E4DA65D8-D235-45A9-AF9C-2EB486EE893D
P2860
1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@ast
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@en
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@nl
type
label
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@ast
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@en
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@nl
prefLabel
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@ast
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@en
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@nl
P2860
P356
P1476
1,5-anhydroglucitol (GlycoMark ...... ntrol and glycemic excursions.
@en
P2093
Kathleen M Dungan
P2860
P356
10.1586/14737159.8.1.9
P577
2008-01-01T00:00:00Z